Related Experiment Videos
Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis
1Lombardi Cancer Center, Department of Pharmacology, Georgetown University Medical Center, Washington, DC 20007, USA. hujj@gunet.georgetown.edu
Pharmacogenetics
|August 1, 1997
Summary
The poly(ADP-ribose) polymerase (PARP) pseudogene genetic polymorphism is not linked to breast cancer risk. However, lower PARP enzyme activity may indicate increased risk in postmenopausal women.
Area of Science:
- Genetics
- Oncology
- Biochemistry
Background:
- The poly(ADP-ribose) polymerase (PARP) enzyme plays a role in DNA repair.
- Genetic variations in PARP pseudogenes may influence cancer development.
- Understanding these factors is crucial for breast cancer research.
Purpose of the Study:
- To investigate the association between a specific PARP pseudogene genetic polymorphism and breast cancer risk.
- To evaluate the relationship between PARP enzyme activity and breast cancer development.
- To explore potential functional links between PARP genotype and enzyme activity.
Main Methods:
- A case-control study involving 309 Caucasian women (≥50 years old).
- Genotyping for the PARP pseudogene (A/B allele) and assessment of PARP enzyme activities.
- Statistical analysis including age adjustment and odds ratio calculation.
Main Results:
- No significant association was found between the PARP B allele frequency and breast cancer status.
- Oligonucleotide-induced PARP enzyme activity was lower in breast cancer cases, suggesting a potential risk indicator.
- H2O2-induced PARP activity was significantly higher in individuals with AB or BB genotypes compared to AA genotype.
Conclusions:
- The studied PARP pseudogene polymorphism is not associated with breast cancer development in this population.
- Oligonucleotide-induced PARP activity may serve as a biomarker for identifying postmenopausal women at higher breast cancer risk.
- A potential functional connection exists between the PARP pseudogene genotype and its enzyme activity.